Skip to content

Comparison of 2 comercially available Toric intraocular lenses in cataract surgery

Comparison of Zeiss and Rayner comercially available Toric intraocular lens implant stability and visual outcomes with standard cataract surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000871246
Enrollment
120
Registered
2009-10-07
Start date
2009-12-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study seeks to compare the stability and visual outcomes of patients recieiving 2 commonly used brands of toric intraocular lens implant (TIOL) used to correct corneal based astigmatism at the time of cataract surgery. Accuracy of implantation as well as post operative stability and effectivity of astigmatic correction will be assessed.

Interventions

Standard cataract surgery was performed through a 2.75mm temporal section with 2 limbal based parancentsis at ninety degrees to the main section. The cataract was removed utilising an intact continuous curvilinear capsulorexhsis and phacemulusification of the lens and a divide and conquer technique. The toric intraocular lens implant (TIOL) (eithe Zeiss or Rayner) was inserted to correct the defocus from the cataractous lens extraction and dialed into the correct orientation to neutralise the co

Standard cataract surgery was performed through a 2.75mm temporal section with 2 limbal based parancentsis at ninety degrees to the main section. The cataract was removed utilising an intact continuous curvilinear capsulorexhsis and phacemulusification of the lens and a divide and conquer technique. The toric intraocular lens implant (TIOL) (eithe Zeiss or Rayner) was inserted to correct the defocus from the cataractous lens extraction and dialed into the correct orientation to neutralise the corneal based astigmatsm. The procedure takes about 40 minutes.

Sponsors

Mater Adults Public hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

Bilateral cataracts at trial entry Age >18 No ocular co-morbidityPatients listed for cataract surgery. The median corneal based astigmatism value of 3 IOL master based readings with less than 1.0 dioptre variation in astigmatism An intact continuous curvilinear capsulorehxsis (CCC) at surgery

Exclusion criteria

The existence of other corneal disease or scarring Failure to achieve repeatable keratometry. Specically a difference of >1.0D astigmatism over 3 readings Phacodonesis noted preoperatively The presence of zonnular dehiscence or capsular bag disruption noted at surgery. Paitents not willing to attend for follow up for the duration of the study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026